The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glyce...
Saved in:
Main Authors: | Chen-Ning Wu, Kai-Jen Tien |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2020/9368583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tissue Factor Expression in Obese Type 2 Diabetic Subjects and Its Regulation by Antidiabetic Agents
by: Jing Wang, et al.
Published: (2015-01-01) -
Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study
by: L. M. Pechmann, et al.
Published: (2020-01-01) -
Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats
by: Yogendra Nayak, et al.
Published: (2014-01-01) -
Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
by: Irene Ruiz-Tamayo, et al.
Published: (2016-01-01) -
Association between sarcopenia and weight-adjusted waist index in male patients with type 2 diabetes
by: Yushuang Xiang, et al.
Published: (2025-01-01)